التفاصيل البيبلوغرافية
| العنوان: |
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial |
| المؤلفون: |
Park, Keunchil, Tan, Eng-Huat, O'Byrne, Ken, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Yang, James Chih-Hsin, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa, Kim, Dong-Wan, Arvis, Catherine Dubos, Kölbeck, Karl, Laurie, Scott A, Tsai, Chun-Ming, Shahidi, Mehdi, Kim, Miyoung, Massey, Dan, Zazulina, Victoria, Paz-Ares, Luis |
| المصدر: |
In The Lancet Oncology May 2016 17(5):577-589 |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder